title: The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia.
abstract: We wanted to investigate the possible etiologic factors of cachexia. Forty-six patients diagnosed with cancer cachexia and 34 healthy controls were included in the study. Serum total testosterone, free testosterone, interleukin 1 (IL) alpha and beta, IL6, tumor necrosis factor (TNF) alpha, orexin, galanin, neuropeptide Y, tumor necrosis factor-like weak inducer of apoptosis and tumor necrosis factor receptor-associated factor 6, and C-reactive protein (CRP) levels were investigated. There were 36 male and 10 female patients in the cachexia group, and 24 male and 10 female patients in the control group. Median overall survival (OS) of the cachexia group after the diagnosis of cachexia was 8 (1-25) months. There were statistically significant relationships between OS and BMI, serum CRP, TRAF-6, albumin, and LDH levels in the cachexia group. In addition to cachexia, serum CRP, testosterone, and TNF alpha levels were statistically significantly correlated with OS in refractory cachexia. TRAF-6 levels was significantly correlated with type of cancer (P = 0.02). Although cachexia presents with a multifactorial ethio-pathogenesis, few of them affect the OS. Our novel results were that serum CRP, albumin, LDH, and TRAF-6 levels have a higher association with OS in patients with cancer cachexia compared to the many other parameters. An ongoing cachexia also called refractory cachexia is a recent definition. This end-stage term of cancer duration may be predicted by decreasing serum testosterone and increasing serum TNF alpha levels, as well as serum CRP levels.
authors: Division of Medical Oncology, Department of Internal Medicine, Bulent Ecevit University School of Medicine, Sultan Orhan Mh 1145 sk No:14, Zonguldak, Turkiye, cebilir@yahoo.com.
authors: Cemil
authors: C
authors: Bilir
authors: Huseyin
authors: H
authors: Engin
authors: Murat
authors: M
authors: Can
authors: Yasemin Bakkal
authors: YB
authors: Temi
authors: Derya
authors: D
authors: Demirtas
mesh_terms: D015415:Biomarkers / Q000097:blood*; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000378:metabolism; D002100:Cachexia / Q000209:etiology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000378:metabolism*; D015850:Interleukin-6 / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000401:mortality / Q000473:pathology; D011379:Prognosis; D012709:Serum Albumin / Q000378:metabolism; D048029:TNF Receptor-Associated Factor 6 / Q000097:blood; D013739:Testosterone / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D015415:Biomarkers; D015850:Interleukin-6; D012709:Serum Albumin; D048029:TNF Receptor-Associated Factor 6; D014409:Tumor Necrosis Factor-alpha; D013739:Testosterone; D002097:C-Reactive Protein; D007770:L-Lactate Dehydrogenase
references: Clin Oncol (R Coll Radiol). 2003 Dec;15(8):443-50
references: 14689999
references: Oncol Rep. 1997 Sep-Oct;4(5):921-6
references: 21590167
references: Am J Med. 1980 Oct;69(4):491-7
references: 7424938
references: Pol Arch Med Wewn. 2001 Aug;106(2):657-68
references: 11926139
references: PLoS One. 2013;8(3):e57436
references: 23469193
references: J Pediatr Endocrinol Metab. 2005 May;18(5):485-9
references: 15921178
references: Nutr Cancer. 2001;39(2):210-3
references: 11759282
references: J Exp Clin Cancer Res. 2012 Sep 26;31:81
references: 23013936
references: Nutr J. 2010 Dec 22;9:69
references: 21176210
references: Support Care Cancer. 2013 Jun;21(6):1569-77
references: 23314651
references: Support Care Cancer. 2008 Mar;16(3):229-34
references: 18071761
references: Annu Rev Nutr. 2006;26:435-61
references: 16602932
references: Nat Rev Drug Discov. 2008 May;7(5):411-25
references: 18404150
references: Folia Histochem Cytobiol. 2010 Sep 30;48(3):407-16
references: 21071347
references: J Cell Biol. 2010 Dec 27;191(7):1395-411
references: 21187332
references: Cancer. 1995 Apr 15;75(8):2077-82
references: 7535184
references: Curr Oncol Rep. 2002 May;4(3):250-5
references: 11937016
references: J Cachexia Sarcopenia Muscle. 2014 Jun;5(2):121-5
references: 24622952